Min Joo Kim

Title: Min Joo Kim: Innovator in Pharmacological Research

Introduction

Min Joo Kim is a notable inventor based in Bucheon, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific receptors in the brain. His work has implications for various medical conditions, showcasing the potential of innovative research in improving health outcomes.

Latest Patents

Min Joo Kim holds 1 patent for his invention titled "Thienopyrimidinone derivatives as mGluR1 antagonists." This patent discloses thienopyrimidinone derivatives that act as antagonists on metabotropic glutamate receptor subtype 1. These derivatives exhibit pharmacological activity against several metabotropic glutamate receptor-related diseases, including neuropathic pain, migraine, anxiety disorders, schizophrenia, urinary incontinence, and neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. The patent also includes methods for preparing these derivatives and pharmaceutical compositions containing them as active ingredients.

Career Highlights

Min Joo Kim is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work is characterized by a commitment to advancing the understanding of pharmacological agents and their therapeutic applications. His innovative approach has positioned him as a key figure in his field.

Collaborations

Min Joo Kim collaborates with esteemed colleagues, including Hyunah Choo and Sun Joon Min. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in pharmacology.

Conclusion

Min Joo Kim's contributions to pharmacological research through his innovative patents highlight the importance of scientific inquiry in addressing complex health issues. His work exemplifies the potential of targeted therapies in improving patient care and advancing medical science.